tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine

C125H82Cl4N12O4Pd4 — CID 157183099

About tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine

tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine (PubChem CID 157183099) has the molecular formula C125H82Cl4N12O4Pd4 and a molecular weight of 2383.60 g/mol. Its IUPAC name is tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine.

Molecular Properties

• Compound Name: tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine
• PubChem CID: 157183099
• Molecular Formula: C125H82Cl4N12O4Pd4
• Molecular Weight: 2383.60 g/mol
• Exact Mass: 2378.15
• IUPAC Name: tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine
• SMILES: Cl[Pd+].Cl[Pd+].Cl[Pd+].Cl[Pd+].Cn1c(-n2c3[c-]c(-c4cc(-c5ccc(-c6ccccc6)cc5)ccn4)ccc3c3ccccc32)nc2ccccc21.[c-]1c(-c2cc(-c3ccc(-c4ccccc4)cc3)ccn2)cccc1-n1c2ccccc2c2ocnc21.[c-]1c(Oc2ccccn2)ccn1-c1cc(-c2ccc(-c3ccccc3)cc2)ccn1.[c-]1c(Oc2nc3ccccc3o2)cccc1-c1cc(-c2ccc(-c3ccccc3)cc2)ccn1
• InChI: InChI=1S/C37H25N4.C32H20N3O.C30H19N2O2.C26H18N3O.4ClH.4Pd/c1-40-35-14-8-6-12-32(35)39-37(40)41-34-13-7-5-11-30(34)31-20-19-29(24-36(31)41)33-23-28(21-22-38-33)27-17-15-26(16-18-27)25-9-3-2-4-10-25;1-2-7-22(8-3-1)23-13-15-24(16-14-23)25-17-18-33-29(20-25)26-9-6-10-27(19-26)35-30-12-5-4-11-28(30)31-32(35)34-21-36-31;1-2-7-21(8-3-1)22-13-15-23(16-14-22)24-17-18-31-28(20-24)25-9-6-10-26(19-25)33-30-32-27-11-4-5-12-29(27)34-30;1-2-6-20(7-3-1)21-9-11-22(12-10-21)23-13-16-27-25(18-23)29-17-14-24(19-29)30-26-8-4-5-15-28-26;;;;;;;;/h2-23H,1H3;1-18,20-21H;1-18,20H;1-18H;4*1H;;;;/q4*-1;;;;;4*+2/p-4
• InChIKey: JRWNNEZLHIUFOB-UHFFFAOYSA-J
• XLogP: 33.59
• TPSA: 167.58 Ų
• H-Bond Acceptors: 16
• Rotatable Bonds: 18
• Heavy Atoms: 149
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2383.60
LogP ≤ 5	33.59
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	16

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine?

The IUPAC name of tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine (CID 157183099) is tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine.

What is the SMILES notation for tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine?

The canonical SMILES for tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine is Cl[Pd+].Cl[Pd+].Cl[Pd+].Cl[Pd+].Cn1c(-n2c3[c-]c(-c4cc(-c5ccc(-c6ccccc6)cc5)ccn4)ccc3c3ccccc32)nc2ccccc21.[c-]1c(-c2cc(-c3ccc(-c4ccccc4)cc3)ccn2)cccc1-n1c2ccccc2c2ocnc21.[c-]1c(Oc2ccccn2)ccn1-c1cc(-c2ccc(-c3ccccc3)cc2)ccn1.[c-]1c(Oc2nc3ccccc3o2)cccc1-c1cc(-c2ccc(-c3ccccc3)cc2)ccn1.

What is the InChIKey of tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine?

The InChIKey is JRWNNEZLHIUFOB-UHFFFAOYSA-J. The full InChI is InChI=1S/C37H25N4.C32H20N3O.C30H19N2O2.C26H18N3O.4ClH.4Pd/c1-40-35-14-8-6-12-32(35)39-37(40)41-34-13-7-5-11-30(34)31-20-19-29(24-36(31)41)33-23-28(21-22-38-33)27-17-15-26(16-18-27)25-9-3-2-4-10-25;1-2-7-22(8-3-1)23-13-15-24(16-14-23)25-17-18-33-29(20-25)26-9-6-10-27(19-26)35-30-12-5-4-11-28(30)31-32(35)34-21-36-31;1-2-7-21(8-3-1)22-13-15-23(16-14-22)24-17-18-31-28(20-24)25-9-6-10-26(19-25)33-30-32-27-11-4-5-12-29(27)34-30;1-2-6-20(7-3-1)21-9-11-22(12-10-21)23-13-16-27-25(18-23)29-17-14-24(19-29)30-26-8-4-5-15-28-26;;;;;;;;/h2-23H,1H3;1-18,20-21H;1-18,20H;1-18H;4*1H;;;;/q4*-1;;;;;4*+2/p-4.

What are the key properties of tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine?

tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine has a molecular weight of 2383.60 g/mol, XLogP of 33.59, 18 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.

Where does this data come from?

All data for tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine is sourced from PubChem (CID 157183099), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).